SS-31
Investigational — Human trials in progressWhat it is
A mitochondria-targeting peptide (elamipretide) studied in human trials for mitochondrial and cardiac conditions.
SS-31 (elamipretide) is a mitochondria-targeting peptide studied in human trials for mitochondrial and cardiac conditions, with mixed results.
Research context
Studied in relation to:
- Mitochondrial-function research
Points in its favour in the literature:
- Human trial data exists
- Targeted mechanism
Caveats and unknowns:
- Investigational, mixed trial results
- Not approved
- Clinician oversight advisable
Handling & reference data
Route in published researchSubcutaneous injection is the route most commonly described in the research literature.
Published clinical / research context (not instructions)Elamipretide trials used ~40 mg once daily subcutaneously (a single 10 mg vial would not cover that).
Storage (lyophilised)Lyophilised (freeze-dried) powder: refrigerate at 2–8 °C short-term, or freeze at −20 °C or below for long-term storage. Keep sealed and out of light.
Reconstituted solutionOnce reconstituted: keep refrigerated (2–8 °C), protect from light, do not freeze. With bacteriostatic water, commonly used within ~4 weeks; with plain sterile water, within ~24–48 h.
Worked reconstitution example (arithmetic only)e.g. 10 mg vial + 2 mL → 5 mg/mL.
Available research formats
| Strength | SKU |
|---|---|
| 10mg | 2S10 |
| 50mg | 2S50 |
Current pricing (THB with USD/GBP conversion) is shown live in the catalogue, which also has a transparent U-100 reconstitution calculator.